Prognostic impact of the number of methylated genes in myelodysplastic syndromes and acute myeloid leukemias treated with azacytidine. | Aplastic Anemia and MDS International Foundation

Prognostic impact of the number of methylated genes in myelodysplastic syndromes and acute myeloid leukemias treated with azacytidine.

Journal Title: 
Ann Hematol
Author(s): 
Abáigar M, Ramos F, Benito R, Díez-Campelo M, Sánchez-Del-Real J, Hermosín L, Rodríguez JN, Aguilar C, Recio I, Alonso JM, de Las Heras N, Megido M, Fuertes M, Del Cañizo MC, Hernández-Rivas JM.
Primary Author: 
Abáigar M
Original Publication Date: 
Thursday, June 6, 2013

No abstract available.

Bone Marrow Diseases: